Semaglutide denied for failing step therapy by Anthem?

Anthem's specific coverage criteria for semaglutide are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Anthem Requires Step Therapy for Semaglutide — and How to Appeal

Anthem's step-therapy (also called "fail-first") requirement for semaglutide means the plan wants evidence that you tried one or more lower-cost or preferred medications first, or that those alternatives are medically inappropriate for you. This is one of the most frequently overturned denial types when members document their history correctly.

## Why This Denial Happens

Anthem's pharmacy and medical policies designate certain medications as preferred within a therapeutic class. Semaglutide may sit at a higher step because of its cost. If your claim lacks documentation of prior therapy with the required step agents — or lacks a clinical reason to skip them — the plan will deny coverage until those boxes are checked.

## Your Federal Appeal Rights

• Internal appeal: File within 180 days of the denial. Standard decisions are due within 30–60 days; urgent (expedited) decisions within 72 hours.
• Step-therapy exception request: Many states have step-therapy exception laws requiring a plan to waive the requirement if a step agent is contraindicated, has already failed, or is clinically inappropriate. Check whether your state has such a law and invoke it explicitly in your appeal letter.
• External review (ACA §2719): After exhausting internal appeals, request independent external review within approximately 4 months of the final denial. The reviewer is not bound by Anthem's step-therapy policy — they apply clinical standards.
• ERISA §503: Employer self-funded plans are subject to full-and-fair review under ERISA; consult an attorney if external review is unavailable.
• Expedited option: Available if your condition is urgent or if waiting for standard review would seriously jeopardize your health.

## Documentation to Gather

1. Prior-treatment history: Pharmacy records, chart notes, and prescriber attestations for every medication you tried at prior steps — including start dates, stop dates, doses used, and outcomes (inadequate response, adverse effect, contraindication). 2. Clinical severity documentation: Chart notes showing your current clinical status and why delay or substitution poses a risk. Reference the applicable guideline organization (such as the ADA or obesity-medicine professional societies) generically. 3. Prescriber medical-necessity letter: Your prescriber should explain, step by step, why each required prior agent was tried and failed or is inappropriate for you, citing the FDA-approved prescribing information for semaglutide as the basis for selecting it now. 4. Anthem's step-therapy policy: Request the full text from Anthem member services. Identify every required step agent and confirm your records address each one.

## Criteria-Mapping Structure

List each step Anthem requires, then map your evidence directly:

| Step Required by Anthem Policy | Your Evidence of Trial or Exception | |---|---| | [Step 1 agent from policy] | [Dates tried, outcome, chart reference] | | [Step 2 agent from policy] | [Dates tried, outcome, or clinical reason skipped] | | [Semaglutide criteria met when…] | [Chart fact confirming eligibility per FDA label] |

Attach all pharmacy records and chart notes as labeled exhibits. The cover letter should cite the denial date, reference the step-therapy exception framework, and request expedited review if clinically appropriate.